Picture of Sartorius Stedim Biotech SA logo

DIM — Sartorius Stedim Biotech SA Share Price

0.000.00%
fr flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m-20.05%
3m-23.54%
6m-22.96%
1yr-2.12%
Volume Change (%)
10d/3m+56.38%
Price vs... (%)
52w High-31.58%
50d MA-17.36%
200d MA-15.41%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)46.69
PEG Ratio (f)3.72
EPS Growth (f)14.36%
Dividend Yield (f)0.47%
Valuation (ttm)IndustryMarket
Price to Book Value20.83
Price to Tang. Bookn/a
Price to Free Cashflow97.84
Price to Sales13.17
EV to EBITDA40.92

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital25.15%
Return on Equity34.53%
Operating Margin28.94%

Financial Summary

Year End 31st DecUnit201620172018201920202021E2022ECAGR / Avg
Total Revenue€m1,051.611,081.031,212.151,440.571,910.082,876.513,339.8616.65%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+35.5+6.54+11.72+30.62+47.1+70.51+14.36n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for DIM

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202131st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2021 / 2022

Blurred out image of Sartorius Stedim Biotech SA EPS forecast chart

Profile Summary

Sartorius Stedim Biotech SA is a France-based international provider of laboratory and process technologies and equipment. The Company covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. The Company’s customers are from the biotech, pharma and food industries, as well as from public research institutes and laboratories. Sartorius operates its own production facilities in Europe, Asia and America, and also has sales offices and local representatives in more than 110 countries. The Company operates through its subsidiaries, including Sartorius Stedim Austria GmbH, Sartorius Stedim Plastics GmbH, BioOutsource Ltd and Wave Biotech AG, among others.

Directors

Last Annual
December 31st, 2020
Last Interim
September 30th, 2021
Incorporated
March 13th, 1983
Public Since
October 20th, 1994
No. of Employees
8,746
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
fr flag iconEuronext - Paris
Shares in Issue
92,180,190

DIM Share Price Performance

Latest News for DIM

Upcoming Events for DIM

Q4 2021 Sartorius AG Earnings Release

Q4 2021 Sartorius AG Earnings Call

Similar to DIM

Affluent Medical SAS

fr flag iconEuronext - Paris

Picture of Alpha MOS SA logo

Alpha MOS SA

fr flag iconEuronext - Paris

Picture of Amplitude Surgical SA logo

Amplitude Surgical SA

fr flag iconEuronext - Paris

Picture of Biomerieux SA logo

Biomerieux SA

fr flag iconEuronext - Paris

FAQ

Or unlock with your email

Or unlock with your email